IBOV 177,512.41 ▼ 0.27% IPSA 11,014.88 ▼ 0.02% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,287,637 ▼ 0.11% COLCAP 2,382.69 ▼ 0.39% BVL PERÚ 57,378.30 — — USD/BRL5.08▲ 0.19% USD/MXN17.32▲ 0.04% USD/CLP924.42▼ 0.72% USD/COP3,228▲ 0.79% USD/PEN3.39▼ 0.08% USD/ARS1,494▲ 0.57% USD/UYU40.27▲ 0.17% USD/PYG5,936▲ 0.08% USD/BOB12.07▼ 0.25% USD/DOP57.83▼ 0.28% USD/CRC448.42— 0.00% USD/GTQ7.62▼ 0.08% USD/HNL26.78▲ 0.07% USD/NIO 36.62 — 0.00% USD/VES746.91▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.10▼ 0.06% USD/TTD6.74▲ 0.40% EUR/BRL5.85▼ 0.14% BRENT 83.83 ▼ 6.98% WTI 80.29 ▼ 5.17% IRON ORE 161.91 — — COPPER 6.55 ▲ 1.69% GOLD 4,110 ▲ 1.50% SILVER 58.41 ▲ 1.41% SOY 1,192 ▲ 1.73% CORN 473.00 ▲ 7.32% WHEAT 651.50 ▲ 1.92% COFFEE 321.15 ▼ 3.30% SUGAR 15.01 ▲ 2.39% ORANGE JUICE 159.20 ▲ 2.74% COTTON 81.39 ▲ 1.11% COCOA 5,903 ▲ 9.38% BEEF 227.03 ▼ 2.04% CATTLE 343.00 ▼ 1.44% LITHIUM 69.40 ▲ 0.26% PETR4 42.86 ▼ 1.29% VALE3 74.36 ▼ 2.52% ITUB4 43.01 ▲ 0.32% BBDC4 18.55 ▲ 0.76% ABEV3 15.81 ▼ 1.13% BBAS3 21.28 ▼ 0.33% B3SA3 15.58 ▼ 0.95% WEGE3 48.35 ▲ 2.44% PRIO3 58.85 ▼ 3.29% SUZB3 43.17 ▼ 0.35% RENT3 38.11 ▲ 1.33% AZZA3 16.28 ▼ 0.85% CSAN3 4.08 ▲ 0.25% RAIZ4 0.25 ▼ 3.85% PCAR3 2.70 ▲ 4.25% GMAT3 4.00 ▼ 0.74% PSSA3 54.13 ▼ 1.04% CVCB3 1.42 ▲ 8.40% POSI3 3.52 ▼ 0.85% SLCE3 13.41 ▲ 0.22% NATU3 8.54 ▲ 1.91% BRKM5 5.90 ▼ 1.17% RANI3 8.42 ▲ 3.82% CSNA3 4.54 ▼ 6.20% CMIN3 5.70 ▼ 0.18% USIM5 7.57 ▲ 2.85% GGBR4 25.43 ▲ 1.80% ENEV3 26.76 ▲ 1.71% CPFE3 45.89 ▼ 0.54% CMIG4 11.28 ▼ 0.53% EQTL3 38.84 ▲ 0.47% LREN3 13.88 ▲ 2.06% VIVT3 32.31 ▼ 0.98% RAIL3 14.14 ▼ 2.08% KLABIN 18.34 ▲ 0.49% RAIA DROGASIL 18.65 ▲ 0.92% RDOR3 34.04 ▼ 1.73% HAPV3 11.87 ▲ 5.23% FLRY3 17.29 ▲ 0.88% SMTO3 14.38 ▼ 0.96% UGPA3 33.10 ▲ 0.15% VBBR3 36.21 ▲ 0.44% BBSE3 41.36 ▲ 0.24% BPAC11 57.28 ▲ 0.85% CURY3 31.55 ▲ 4.85% AERI3 2.14 ▼ 0.47% VIVARA 22.87 ▲ 3.11% COMPASS 24.98 ▲ 0.56% VAMOS 3.28 ▼ 1.80% SANB11 28.95 ▲ 1.15% ASAI3 8.48 ▼ 0.24% SBSP3 27.41 ▼ 1.05% WALMEX 49.74 ▼ 1.01% GMEXICO 211.84 ▲ 1.98% FEMSA 216.60 ▼ 2.19% CEMEX 20.58 ▲ 0.34% GFNORTE 198.18 ▼ 1.20% BIMBO 61.35 ▼ 0.98% TELEVISA 9.61 ▼ 2.04% AMX 21.55 ▼ 2.36% GAP 376.50 ▼ 0.01% ASUR 275.26 ▼ 0.13% OMA 230.88 ▼ 0.19% KOF 185.34 ▼ 1.03% GRUMA 264.28 ▲ 2.34% KIMBER 40.06 ▼ 0.35% SQM-B 61,752 ▼ 1.51% COPEC 6,275 ▼ 1.18% BSANTANDER 79.86 ▼ 1.40% FALABELLA 6,303 ▲ 1.41% ENELAM 87.23 ▼ 0.86% CENCOSUD 1,955 ▲ 0.01% CMPC 1,063 ▲ 0.77% BANCO CHILE 191.61 ▼ 1.08% LATAM AIR 25.25 ▲ 2.06% YPF 8,110 ▼ 2.17% GGAL 7,945 ▲ 0.80% PAMPA 5,510 ▼ 0.81% TXAR 656.50 ▼ 0.45% ALUAR 969.50 ▼ 0.82% TGS 9,865 ▼ 1.84% CEPU 2,371 ▼ 1.04% MIRGOR 1,675 ▼ 89.76% COME 43.50 ▼ 1.20% LOMA NEGRA 3,575 ▼ 1.24% BYMA 293.50 ▼ 0.68% TELECOM ARG 4,383 ▼ 0.57% ECOPETROL 16.61 ▼ 0.98% BANCOLOMBIA 91.14 ▼ 1.49% GRUPO AVAL 5.21 ▼ 1.33% CREDICORP 395.87 ▼ 1.18% SOUTHERN COPPER 186.47 ▲ 2.06% BUENAVENTURA 30.38 ▲ 0.33% MERCADOLIBRE 1,899 ▲ 1.13% NUBANK 14.47 ▲ 0.98% XP 17.01 ▼ 0.29% PAGSEGURO 9.63 ▼ 0.10% STONE 11.32 ▼ 0.48% GLOBANT 37.60 ▲ 2.73% TECNOGLASS 46.48 ▲ 7.00% GAP AIRPORT 217.46 ▲ 0.05% ASUR 275.26 ▼ 0.13% OMA AIRPORT 106.42 ▼ 0.45% AMX ADR 24.87 ▼ 1.89% FEMSA ADR 125.02 ▼ 2.32% CEMEX ADR 11.89 ▲ 0.55% PETROBRAS ADR 19.09 ▼ 1.62% VALE ADR 14.57 ▼ 3.25% ITAU ADR 8.46 ▼ 0.02% SANTANDER BR 5.73 ▲ 0.97% AMBEV ADR 3.07 ▼ 1.29% CSN 0.91 ▼ 7.94% GERDAU 5.01 ▲ 1.01% LATAM ADR 54.41 ▲ 3.13% BTC 63,898 ▲ 0.65% ETH 1,870 ▼ 0.66% SOL 74.00 ▲ 0.75% XRP 1.08 ▼ 0.48% BNB 591.57 ▲ 0.68% ADA 0.19 ▲ 2.41% DOGE 0.07 ▼ 0.48% AVAX 6.59 ▲ 0.68% LINK 8.25 ▼ 1.43% DOT 0.83 ▲ 3.58% LTC 44.31 ▼ 0.73% BCH 213.86 ▲ 0.63% TRX 0.33 ▲ 0.69% XLM 0.17 ▼ 1.05% HBAR 0.07 ▲ 0.70% NEAR 1.74 ▲ 1.43% ATOM 1.36 ▲ 7.84% AAVE 93.05 ▲ 1.14% SELIC 14.25% EMBRAER 90.56 ▲ 4.22% EMBRAER ADR 71.24 ▲ 4.26% JBS 13.76 ▼ 1.89% JBS BDR 69.95 ▼ 1.06% MBRF3 17.70 ▲ 0.91% MBRFY 3.43 ▼ 0.29% INTER 5.60 ▼ 0.09% IBOV 177,512.41 ▼ 0.27% IPSA 11,014.88 ▼ 0.02% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,287,637 ▼ 0.11% COLCAP 2,382.69 ▼ 0.39% BVL PERÚ 57,378.30 — — USD/BRL 5.08 ▲ 0.19% USD/MXN 17.32 ▲ 0.04% USD/CLP 924.42 ▼ 0.72% USD/COP 3,228 ▲ 0.79% USD/PEN 3.39 ▼ 0.08% USD/ARS 1,494 ▲ 0.57% USD/UYU 40.27 ▲ 0.17% USD/PYG 5,936 ▲ 0.08% USD/BOB 12.07 ▼ 0.25% USD/DOP 57.83 ▼ 0.28% USD/CRC 448.42 ▲ 0.00% USD/GTQ 7.62 ▼ 0.08% USD/HNL 26.78 ▲ 0.07% USD/NIO 36.62 — 0.00% USD/VES 746.91 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.10 ▲ 0.31% USD/TTD 6.74 ▲ 1.26% EUR/BRL 5.85 ▼ 0.14% BRENT 83.83 ▼ 6.98% WTI 80.29 ▼ 5.17% IRON ORE 161.91 — — COPPER 6.55 ▲ 1.69% GOLD 4,110 ▲ 1.50% SILVER 58.41 ▲ 1.41% SOY 1,192 ▲ 1.73% CORN 473.00 ▲ 7.32% WHEAT 651.50 ▲ 1.92% COFFEE 321.15 ▼ 3.30% SUGAR 15.01 ▲ 2.39% ORANGE JUICE 159.20 ▲ 2.74% COTTON 81.39 ▲ 1.11% COCOA 5,903 ▲ 9.38% BEEF 227.03 ▼ 2.04% CATTLE 343.00 ▼ 1.44% LITHIUM 69.40 ▲ 0.26% PETR4 42.86 ▼ 1.29% VALE3 74.36 ▼ 2.52% ITUB4 43.01 ▲ 0.32% BBDC4 18.55 ▲ 0.76% ABEV3 15.81 ▼ 1.13% BBAS3 21.28 ▼ 0.33% B3SA3 15.58 ▼ 0.95% WEGE3 48.35 ▲ 2.44% PRIO3 58.85 ▼ 3.29% SUZB3 43.17 ▼ 0.35% RENT3 38.11 ▲ 1.33% AZZA3 16.28 ▼ 0.85% CSAN3 4.08 ▲ 0.25% RAIZ4 0.25 ▼ 3.85% PCAR3 2.70 ▲ 4.25% GMAT3 4.00 ▼ 0.74% PSSA3 54.13 ▼ 1.04% CVCB3 1.42 ▲ 8.40% POSI3 3.52 ▼ 0.85% SLCE3 13.41 ▲ 0.22% NATU3 8.54 ▲ 1.91% BRKM5 5.90 ▼ 1.17% RANI3 8.42 ▲ 3.82% CSNA3 4.54 ▼ 6.20% CMIN3 5.70 ▼ 0.18% USIM5 7.57 ▲ 2.85% GGBR4 25.43 ▲ 1.80% ENEV3 26.76 ▲ 1.71% CPFE3 45.89 ▼ 0.54% CMIG4 11.28 ▼ 0.53% EQTL3 38.84 ▲ 0.47% LREN3 13.88 ▲ 2.06% VIVT3 32.31 ▼ 0.98% RAIL3 14.14 ▼ 2.08% KLABIN 18.34 ▲ 0.49% RAIA DROGASIL 18.65 ▲ 0.92% RDOR3 34.04 ▼ 1.73% HAPV3 11.87 ▲ 5.23% FLRY3 17.29 ▲ 0.88% SMTO3 14.38 ▼ 0.96% UGPA3 33.10 ▲ 0.15% VBBR3 36.21 ▲ 0.44% BBSE3 41.36 ▲ 0.24% BPAC11 57.28 ▲ 0.85% CURY3 31.55 ▲ 4.85% AERI3 2.14 ▼ 0.47% VIVARA 22.87 ▲ 3.11% COMPASS 24.98 ▲ 0.56% VAMOS 3.28 ▼ 1.80% SANB11 28.95 ▲ 1.15% ASAI3 8.48 ▼ 0.24% SBSP3 27.41 ▼ 1.05% WALMEX 49.74 ▼ 1.01% GMEXICO 211.84 ▲ 1.98% FEMSA 216.60 ▼ 2.19% CEMEX 20.58 ▲ 0.34% GFNORTE 198.18 ▼ 1.20% BIMBO 61.35 ▼ 0.98% TELEVISA 9.61 ▼ 2.04% AMX 21.55 ▼ 2.36% GAP 376.50 ▼ 0.01% ASUR 275.26 ▼ 0.13% OMA 230.88 ▼ 0.19% KOF 185.34 ▼ 1.03% GRUMA 264.28 ▲ 2.34% KIMBER 40.06 ▼ 0.35% SQM-B 61,752 ▼ 1.51% COPEC 6,275 ▼ 1.18% BSANTANDER 79.86 ▼ 1.40% FALABELLA 6,303 ▲ 1.41% ENELAM 87.23 ▼ 0.86% CENCOSUD 1,955 ▲ 0.01% CMPC 1,063 ▲ 0.77% BANCO CHILE 191.61 ▼ 1.08% LATAM AIR 25.25 ▲ 2.06% YPF 8,110 ▼ 2.17% GGAL 7,945 ▲ 0.80% PAMPA 5,510 ▼ 0.81% TXAR 656.50 ▼ 0.45% ALUAR 969.50 ▼ 0.82% TGS 9,865 ▼ 1.84% CEPU 2,371 ▼ 1.04% MIRGOR 1,675 ▼ 89.76% COME 43.50 ▼ 1.20% LOMA NEGRA 3,575 ▼ 1.24% BYMA 293.50 ▼ 0.68% TELECOM ARG 4,383 ▼ 0.57% ECOPETROL 16.61 ▼ 0.98% BANCOLOMBIA 91.14 ▼ 1.49% GRUPO AVAL 5.21 ▼ 1.33% CREDICORP 395.87 ▼ 1.18% SOUTHERN COPPER 186.47 ▲ 2.06% BUENAVENTURA 30.38 ▲ 0.33% MERCADOLIBRE 1,899 ▲ 1.13% NUBANK 14.47 ▲ 0.98% XP 17.01 ▼ 0.29% PAGSEGURO 9.63 ▼ 0.10% STONE 11.32 ▼ 0.48% GLOBANT 37.60 ▲ 2.73% TECNOGLASS 46.48 ▲ 7.00% GAP AIRPORT 217.46 ▲ 0.05% ASUR 275.26 ▼ 0.13% OMA AIRPORT 106.42 ▼ 0.45% AMX ADR 24.87 ▼ 1.89% FEMSA ADR 125.02 ▼ 2.32% CEMEX ADR 11.89 ▲ 0.55% PETROBRAS ADR 19.09 ▼ 1.62% VALE ADR 14.57 ▼ 3.25% ITAU ADR 8.46 ▼ 0.02% SANTANDER BR 5.73 ▲ 0.97% AMBEV ADR 3.07 ▼ 1.29% CSN 0.91 ▼ 7.94% GERDAU 5.01 ▲ 1.01% LATAM ADR 54.41 ▲ 3.13% BTC 63,898 ▲ 0.65% ETH 1,870 ▼ 0.66% SOL 74.00 ▲ 0.75% XRP 1.08 ▼ 0.48% BNB 591.57 ▲ 0.68% ADA 0.19 ▲ 2.41% DOGE 0.07 ▼ 0.48% AVAX 6.59 ▲ 0.68% LINK 8.25 ▼ 1.43% DOT 0.83 ▲ 3.58% LTC 44.31 ▼ 0.73% BCH 213.86 ▲ 0.63% TRX 0.33 ▲ 0.69% XLM 0.17 ▼ 1.05% HBAR 0.07 ▲ 0.70% NEAR 1.74 ▲ 1.43% ATOM 1.36 ▲ 7.84% AAVE 93.05 ▲ 1.14% SELIC 14.25% EMBRAER 90.56 ▲ 4.22% EMBRAER ADR 71.24 ▲ 4.26% JBS 13.76 ▼ 1.89% JBS BDR 69.95 ▼ 1.06% MBRF3 17.70 ▲ 0.91% MBRFY 3.43 ▼ 0.29% INTER 5.60 ▼ 0.09%
since 2009
Monday, August 3, 2026

Covid-19: Israeli doctors and scientists warn FDA about reliability and legitimacy of official Israeli vaccine data

By · October 26, 2021 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – An independent Israeli group of physicians, lawyers, scientists, and researchers called the Professional Ethics Front today advised the U.S. Food and Drug Administration (FDA) regarding the upcoming FDA discussion on administering COVID-19 vaccines to children aged 5-11, expressing “severe concerns” regarding the reliability and legality of official Israeli COVID vaccine data.

“We are aware that the state of Israel is perceived as ‘the world laboratory’ regarding the safety and efficacy of the Pfizer-BioNTech COVID-19 vaccine, as reflected by statements made by Dr. Albert Bourla, Dr. Anthony Fauci, and other senior figures in leading health authorities throughout the world,” the letter reads.

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

“It is, therefore, our understanding that the data and information coming from Israel play a crucial role in critical decision-making processes in regards to COVID-19 vaccination policies. We thus see it of utmost importance to convey a message of warning and raise our major concerns regarding potential flaws in the reliability of the Israeli data with respect to the Pfizer-BioNTech COVID-19 vaccine, as well as many significant legal and ethical violations that accompany the data collection processes.”

(On September 30th, Israeli Ministry of Health deleted thousands of comments and testimonies about vac(x)ine adverse effects. Journalist Avi Barak explains  how it unfolded)

The letter elaborates: “We believe that the significant failures underlying the Israeli database, which have been brought to our attention by numerous testimonies, impair its reliability and legality to such an extent that it should not be used for making any critical decisions regarding the COVID-19 vaccines.”

“This document briefly outlines the main failures that lead to this unfortunate, albeit inevitable, conclusion,” the notice reads. “We emphasize that we can expand and clarify further, as well as provide references, in relation to each of the failures described below:

  • Lack of a Public and Transparent Adverse Events (AE) Reporting System
  • Severe Impairments in Healthcare Professionals’ Adverse Events Reporting System
  • Reports, which the Israeli MOH does publicize about the AEs observed after receiving the Pfizer-BIONtech COVID-19 vaccine, are not consistent with the testimonies of physicians regarding severe adverse events (SAEs) that they themselves have reported to the MOH.
  • Data Distortion: Recently, two serious incidents in which data presented by the MOH was distorted have been revealed.
  • Legal and Ethical Violations in Data Collection Processes

The Israeli Professional Ethics Front concludes its notice to the FDA: “In accordance with the accepted perception established after World War II, the findings of experiments obtained in illegal and immoral ways should not be relied upon.”

“We believe that the same rules should apply to the findings of the current experiment in Israel since these findings were obtained through significant legal and ethical infringements.”

“Our conclusion is further reinforced by the significant doubts about the reliability of the data reported by Israel, as detailed above, and the consequent major concern that their use might be misleading and thus disrupt the decision-making processes pertaining to the Pfizer-BioNTech COVID-19 vaccines.”

The letter is signed by Dr. Sorin Schapira, MBA, Eitan Marchand, Dr. Moran Kronenberg, Dr. Sergei Bianover, Ph.D, Prof. Alon Warburg, Dr. Boaz Ilan, Prof. Eti Einhorn, Dr. Daniel Mishori, Adv. Orly Yaron, Prof. Natti Ronel, Dr. Ety Elisha, Adv. Dana Kovalskiy, Adv. Galit Polatchek, Adv. Yoram Morim, Dr. Yaffa Shir-Raz, Adv. Yossi Bitton, Adv. Valentina Nelin, Dr. Ilan Makover, MD, Osnat Navon, Dr. Itsik Vorgaft, and Dr. Yael Stein, MD.

Join us on Telegram: t.me/theriotimes

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.